Sustained Leukemia-Free State and Molecular Response to Sorafenib in a Patient With Chronic Myelomonocytic Leukemia in Transformation Driven by Homozygous FLT3-ITD Malignant Hematopoiesis

被引：2
作者：
Kosmider, Olivier [1 ,2 ,3 ]
Chapuis, Nicolas [1 ,2 ,3 ]
Kaltenbach, Sophie [3 ,4 ]
Coriat, Romain [3 ]
Rouquette, Pascaline Boudou [3 ,5 ]
Willems, Lise [2 ,3 ,6 ]
Chesnais, Virginie [2 ,3 ]
Radford-Weiss, Isabelle [3 ,4 ]
Bardet, Valerie [1 ,2 ,3 ]
Mayeux, Patrick [2 ,3 ]
Tamburini, Jerome [2 ,3 ,6 ]
Fontenay, Michaela [1 ,2 ,3 ]
Bouscary, Didier [2 ,3 ,6 ]
机构：
[1] Hop Cochin, AP HP, Serv Hematol Biol, F-75674 Paris, France
[2] CNRS, INSERM, Inst Cochin, Dept Immunohematol,UMR8104,U1016, Paris, France
[3] Univ Paris 05, Fac Med Sorbonne, Paris, France
[4] Hop Necker Enfants Malad, AP HP, Cytogenet Serv, Paris, France
[5] Hop Cochin, AP HP, Ctr Rech Inhibiteurs Angiogenese CERIA, F-75674 Paris, France
[6] Hop Cochin, AP HP, UF Hematol, F-75674 Paris, France
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2013年 / 13卷 / 03期
关键词：
ASXL1; mutation; CMML; Targeted therapy; FLT3-ITD; Sorafenib; ACUTE MYELOID-LEUKEMIA; WILD-TYPE ALLELE; MYELODYSPLASTIC SYNDROMES; ASXL1; MUTATIONS; COMBINATION; CYTARABINE; MODEL;
D O I：
10.1016/j.clml.2012.11.007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：347 / 350
页数：4
相关论文
共 14 条
  • [1] Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trial
    Braun, Thorsten
    Itzykson, Raphael
    Renneville, Aline
    de Renzis, Benoit
    Dreyfus, Francois
    Laribi, Kamel
    Bouabdallah, Krimo
    Vey, Norbert
    Toma, Andrea
    Recher, Christian
    Royer, Bruno
    Joly, Bertrand
    Vekhoff, Anne
    Lafon, Ingrid
    Sanhes, Laurence
    Meurice, Guillaume
    Orear, Cedric
    Preudhomme, Claude
    Gardin, Claude
    Ades, Lionel
    Fontenay, Michaela
    Fenaux, Pierre
    Droin, Nathalie
    Solary, Eric
    [J]. BLOOD, 2011, 118 (14) : 3824 - 3831
  • [2] Loss-of-function Additional sex combs like 1 mutations disrupt hematopoiesis but do not cause severe myelodysplasia or leukemia
    Fisher, Cynthia L.
    Pineault, Nicolas
    Brookes, Christy
    Helgason, Cheryl D.
    Ohta, Hideaki
    Bodner, Caroline
    Hess, Jay L.
    Humphries, R. Keith
    Brock, Hugh W.
    [J]. BLOOD, 2010, 115 (01) : 38 - 46
  • [3] Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia
    Gelsi-Boyer, Veronique
    Trouplin, Virginie
    Adelaide, Jose
    Bonansea, Julien
    Cervera, Nathalie
    Carbuccia, Nadine
    Lagarde, Arnaud
    Prebet, Thomas
    Nezri, Meyer
    Sainty, Danielle
    Olschwang, Sylviane
    Xerri, Luc
    Chaffanet, Max
    Mozziconacci, Marie-Joelle
    Vey, Norbert
    Birnbaum, Daniel
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2009, 145 (06) : 788 - 800
  • [4] Knock-in of a FLT3/ITD mutation cooperates with a NUP98-HOXD13 fusion to generate acute myeloid leukemia in a mouse model
    Greenblatt, Sarah
    Li, Li
    Slape, Christopher
    Bao Nguyen
    Novak, Rachel
    Duffield, Amy
    Huso, David
    Desiderio, Stephen
    Borowitz, Michael J.
    Aplan, Peter
    Small, Donald
    [J]. BLOOD, 2012, 119 (12) : 2883 - 2894
  • [5] Phase I Pharmacokinetic and Pharmacodynamic Study of the Multikinase Inhibitor Sorafenib in Combination With Clofarabine and Cytarabine in Pediatric Relapsed/Refractory Leukemia
    Inaba, Hiroto
    Rubnitz, Jeffrey E.
    Coustan-Smith, Elaine
    Li, Lie
    Furmanski, Brian D.
    Mascara, Gerard P.
    Heym, Kenneth M.
    Christensen, Robbin
    Onciu, Mihaela
    Shurtleff, Sheila A.
    Pounds, Stanley B.
    Pui, Ching-Hon
    Ribeiro, Raul C.
    Campana, Dario
    Baker, Sharyn D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (24) : 3293 - 3300
  • [6] Impact of gene dosage, loss of wild-type allele, and FLT3 ligand on Flt3-ITD-induced myeloproliferation
    Kharazi, Shabnam
    Mead, Adam J.
    Mansour, Anna
    Hultquist, Anne
    Boiers, Charlotta
    Luc, Sidinh
    Buza-Vidas, Natalija
    Ma, Zhi
    Ferry, Helen
    Atkinson, Debbie
    Reckzeh, Kristian
    Masson, Kristina
    Cammenga, Jorg
    Ronnstrand, Lars
    Arai, Fumio
    Suda, Toshio
    Nerlov, Claus
    Sitnicka, Ewa
    Jacobsen, Sten Eirik W.
    [J]. BLOOD, 2011, 118 (13) : 3613 - 3621
  • [7] FLT3 mutations confer enhanced proliferation and survival properties to multipotent progenitors in a murine model of chronic myelomonocytic leukemia
    Lee, Benjamin H.
    Tothova, Zuzana
    Levine, Ross L.
    Anderson, Kristina
    Buza-Vidas, Natalija
    Cullen, Dana E.
    McDowell, Elizabeth P.
    Adelsperger, Jennifer
    Frhling, Stefan
    Huntly, Brian J. P.
    Beran, Miloslav
    Jacobsen, Sten Eirik
    Gilliland, D. Gary
    [J]. CANCER CELL, 2007, 12 (04) : 367 - 380
  • [8] Loss of the wild-type allele contributes to myeloid expansion and disease aggressiveness in FLT3/ITD knockin mice
    Li, Li
    Bailey, Emily
    Greenblatt, Sarah
    Huso, David
    Small, Donald
    [J]. BLOOD, 2011, 118 (18) : 4935 - 4945
  • [9] Sorafenib treatment of FLT3-ITD+ acute myeloid leukemia: favorable initial outcome and mechanisms of subsequent nonresponsiveness associated with the emergence of a D835 mutation
    Man, Cheuk Him
    Fung, Tsz Kan
    Ho, Christa
    Han, Heron H. C.
    Chow, Howard C. H.
    Ma, Alvin C. H.
    Choi, William W. L.
    Lok, Si
    Cheung, Alice M. S.
    Eaves, Connie
    Kwong, Yok Lam
    Leung, Anskar Y. H.
    [J]. BLOOD, 2012, 119 (22) : 5133 - 5143
  • [10] ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category
    Metzeler, Klaus H.
    Becker, Heiko
    Maharry, Kati
    Radmacher, Michael D.
    Kohlschmidt, Jessica
    Mrozek, Krzysztof
    Nicolet, Deedra
    Whitman, Susan P.
    Wu, Yue-Zhong
    Schwind, Sebastian
    Powell, Bayard L.
    Carter, Thomas H.
    Wetzler, Meir
    Moore, Joseph O.
    Kolitz, Jonathan E.
    Baer, Maria R.
    Carroll, Andrew J.
    Larson, Richard A.
    Caligiuri, Michael A.
    Marcucci, Guido
    Bloomfield, Clara D.
    [J]. BLOOD, 2011, 118 (26) : 6920 - 6929
12